Last reviewed · How we verify
Envafolimab with old manufacturing process — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Envafolimab with old manufacturing process (Envafolimab with old manufacturing process) — 3D Medicines (Sichuan) Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Envafolimab with old manufacturing process TARGET | Envafolimab with old manufacturing process | 3D Medicines (Sichuan) Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Envafolimab with old manufacturing process CI watch — RSS
- Envafolimab with old manufacturing process CI watch — Atom
- Envafolimab with old manufacturing process CI watch — JSON
- Envafolimab with old manufacturing process alone — RSS
Cite this brief
Drug Landscape (2026). Envafolimab with old manufacturing process — Competitive Intelligence Brief. https://druglandscape.com/ci/envafolimab-with-old-manufacturing-process. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing